Balloon catheter vs oxytocin alone for induction of labor in women with a previous cesarean section: A randomized controlled trial.


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
02 2020
Historique:
received: 22 08 2018
accepted: 12 08 2019
pubmed: 23 8 2019
medline: 30 4 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

The aim of this study was to compare the efficacy and maternal-neonatal morbidity between balloon catheter and oxytocin for induction of labor in women with a previous cesarean section and an unfavorable cervix. This open-label randomized controlled trial took place in seven French hospitals. Inclusion criteria were medical indication for labor induction in pregnant women, ≥37 weeks, with lower segment cesarean section, Bishop score ≤4, no pre-labor rupture of membranes, singleton fetus in cephalic presentation. Women were allocated randomly to induction with a 50-mL balloon catheter for 12 hours or a low-dose oxytocin infusion. Primary outcome was the rate of vaginal birth. Secondary outcomes were maternal and neonatal complications. The study enrolled 204 women from 26 December 2010 to 31 December 2013: 101 were allocated to receive balloon catheter and 103 to oxytocin. Vaginal birth rate was 50% (n = 51) in the balloon catheter group vs 37% (n = 38) in the oxytocin group (P = 0.050). Maternal and neonatal morbidity did not differ between balloon catheter and oxytocin groups: two uterine dehiscences vs one, one vs four maternal infections, five vs two hemorrhages and 11 vs five neonatal transfers, respectively. Heterogeneity of treatment effect for vaginal delivery was observed across initial Bishop scores. Balloon catheter was more effective for low values of bishop score. Balloon catheter tended to be associated with a higher probability of vaginal delivery as compared with low-dose intravenous oxytocin when used for induction of labor in women with a previous cesarean section and low Bishop score at induction.

Identifiants

pubmed: 31432510
doi: 10.1111/aogs.13712
doi:

Substances chimiques

Oxytocics 0
Oxytocin 50-56-6

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-266

Subventions

Organisme : Programme Hospitalier de Recherche Clinique Interrégional 2010
ID : A00409-30
Pays : International

Informations de copyright

© 2019 Nordic Federation of Societies of Obstetrics and Gynecology.

Références

Blondel B, Lelong N, Kermarrec M, Goffinet F; National Coordination Group of the National Perinatal Surveys. Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys. J Gynecol Obstet Biol Reprod. 2012;41:e1-e15.
Vogel JP, Betran AP, Vindevoghel N, et al. Use of the Robson classification to assess caesarean section trends in 21 countries: a secondary analysis of two WHO multicountry surveys. Lancet. 2015;3:e260-e270.
Royal College of Obstetricians and Gynaecologists. Birth after Previous Caesarean Birth. Green-top Guideline No.45. London: RCOG; 2015.
ACOG Practice Bulletin no. 107. Vaginal birth after a previous cesarean delivery. Obstet Gynecol. 2009;114:386-397.
Deruelle P, Lepage J, Depret S, Clouqueur E. Induction of labor and intrapartum management for women with uterine scar. (In French.) J Gyn Obstet Med Reprod. (Paris). 2012;41:788-802.
West HM, Jozwiak M, Dodd JM. Methods of term labour induction for women with a previous caesarean section. Cochrane Database Syst Rev. 2017;(6):CD009792.
Jozwiak M, Rengerink KO, Benthem M, et al, for the PROBAAT study group. Foley catheter vs vaginal prostaglandin E2 gel for induction of labor at term (PROBAAT trial): an open-label, randomised controlled trial. Lancet. 2011;378:2095-2103.
Jozwiak M, Rengering KO, Ten Eikelder ML, et al. Foley catheter or prostaglandins E2 inserts for induction of labour at term: an open-label randomised controlled trial (PROBAAT-P Trial) and systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2013;170:137-145.
Vaknin Z, Kurweil Y, Sherman D. Foley catheter balloon vs locally applied prostaglandins for cervical ripening and labor induction: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;203:418-429.
Cromi A, Ghezzi F, Uccella S, et al. A randomised trial of preinduction cervical ripening: dinoprostone vaginal insert vs double-balloon catheter. Am J Obstet Gynecol. 2012;207(125):e1-e7.
Bujold E, Blackwell SC, Gauthier RJ. Cervical ripening with transcervical Foley catheter and the risk of uterine rupture. Obstet Gynecol. 2004;103:18-23.
Ravasia DJ, Wood SL, Pollard JK. Uterine rupture during induced trial of labor among women with previous cesarean delivery. Am J Obstet Gynecol. 2000;183:1176-1179.
Sarreau M, Leufflen L, Monceau E, et al. Balloon catheter for cervical ripening on scarred uterus with unfavorable cervix: multicenter retrospective study of 151 patients. (In French). J Gynecol Obstet Med Reprod. 2014;43:46-55.
Ziyauddin F, Hakim S, Beriwal S. The transcervical foley catheter vs the vaginal prostaglandin E2 gel in the induction of labor in a previous one cesarean section - a clinical study. J Clin Diag. 2013;7:140-143.
Jozwiak M, Van de Lest HA, Burger N, Dijksterhuis M. Willem de Leeuw J. Cervical ripening with foley catheter for induction of labor after cesarean section: a cohort study. Acta Obstet Gynecol Scand. 2014;93:296-301.
Sananes N, Rodriguez M, Stora C, et al. Efficacy and safety of labor induction in patients with a single previous Cesarean section: a proposal for a clinical protocol. Arch Gynecol Obstet. 2014;290:669-696.
Ben-Aroya Z, Hallak M, Segal D, Friger M, Katz M, Mazor M. Ripening of the uterine cervix in a post cesarean parturient prostaglandin vs Foley catheter. J Matern Fetal Neonat Med. 2002;12:42-45.
Kehl S, Weiss C, Rath W. Balloon catheter for induction of labor at term after previous cesarean section: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2016;204:44-50.
Haumonte JB, Raylet M, Sabiani L, et al. Predictive factors for vaginal birth after cesarean section. J Gynecol Obstet Med Reprod. 2012;41:735-752.
Zelop CM, Thomas D, Repke ST, Cohen A, Caughey AB, Lieberman E. Uterine rupture during induced or augmented labor in gravid women with one prior cesarean delivery. Am J Obstet Gynecol. 1999;181:882-886.
Lydon Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. New Engl J Med. 2001;345:3-8.
Lamourdedieu C, Gnisci A, Agostini A. Risk of uterine rupture after cervical ripening with balloon catheter on uterus with previous cesarean section. J Gynecol Obstet Biol Reprod. 2016;45:496-501.
Heinemann J, Gillen G, Sanchez Ramos L, Kauritz M. Do mecanical methods of cervical ripening increase infectious morbidity? A systematic review. Am J Obstet Gynecol. 2008;8:177-188.
Levy R, Kanengiser B, Furman B, Arie AB, Brown D, Hagay ZJ. A randomised trial comparing a 30 mL and an 80 mL Foley catheter balloon for preinduction cervical ripening. Am J Obstet Gynecol. 2004;191:1632-1636.
Kashanian M, Nazemi M, Malakzadegan A. Comparison of 30 mL and 80 mL Foley catheter balloons and oxytocin for preinduction cervical ripening. Int J Gynaecol Obstet. 2009;105:174-175.
Delaney S, Shaffer BL, Chen YW, et al. Labor induction with a Foley balloon inflated to 30 mL compared with 60 mL: randomised controlled trial. Obstet Gynecol. 2010;115:1239-1245.
Gu N, Ru T, Wang Z, et al. Foley catheter for induction of labor at term: an open-label, randomised controlled trial. PLoS ONE. 2015;10:e0136856.
Pennell CE, Henderson JJ, O Neill MJ, Mc Cleery S, Doherti DA, Dickinson JE. Induction of labor in nulliparous women with an unfavorable cervix: a randomised controlled trial comparing double and single balloon catheter and PGE2 gel. BJOG 2009;116:1443-1452.
Ruhstaller K. Induction of labor in the obese patient. Semin Perinatol. 2015;39:437-440.

Auteurs

Mélie Sarreau (M)

Department of Obstetrics and Gynecology, University Hospital of Poitiers, Poitiers, France.
Department of Obstetrics and Gynecology, Regional Hospital of Angoulême, Angoulême, France.

Helene Isly (H)

Department of Obstetrics and Gynecology, University Hospital of Rennes, Rennes, France.
Faculty of Medicine, University of Rennes, Rennes, France.

Patrice Poulain (P)

Department of Obstetrics and Gynecology, University Hospital of Rennes, Rennes, France.
Faculty of Medicine, University of Rennes, Rennes, France.

Brigitte Fontaine (B)

Department of Obstetrics and Gynecology, Regional Hospital of Angoulême, Angoulême, France.

Olivier Morel (O)

Department of Obstetrics and Gynecology, University Hospital, Nancy, France.
Faculty of Medicine, University of Lorraine, Nancy, France.

Pascal Villemonteix (P)

Department of Obstetrics and Gynecology, Regional Hospital of Nord de Sèvres, Bressuire, France.

Pierre Mares (P)

Department of Obstetrics and Gynecology, University of Nîmes, Nîmes, France.
Faculty of Medicine, University of Nîmes, Nîmes, France.

Eve Mousty (E)

Department of Obstetrics and Gynecology, University of Nîmes, Nîmes, France.
Faculty of Medicine, University of Nîmes, Nîmes, France.

Alain Godard (A)

Department of Obstetrics and Gynecology, General Hospital Camille Guérin, Chatellerault, France.

Stephanie Ragot (S)

Faculty of Medicine, University of Poitiers, Poitiers, France.
Clinical Epidemiology and Health Research Center, University of Poitiers, Poitiers, France.
National Health and Medical Research Institute (INSERM), CIC 1402, Poitiers, France.

Fabrice Pierre (F)

Department of Obstetrics and Gynecology, University Hospital of Poitiers, Poitiers, France.
Faculty of Medicine, University of Poitiers, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH